Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.55 |
| ▸ | CA1 | P00915 | 2/20 | 0.55 |
| ▸ | CA2 | P00918 | 2/20 | 0.55 |
| ▸ | CA7 | P43166 | 2/20 | 0.55 |
| ▸ | CA9 | Q16790 | 2/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.46 |
| ▸ | NPC1 | O15118 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | MRGPRX4 | Q96LA9 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13945260 | 0.98 | CA12 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13498485 | 0.81 | PARP10 (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL183994 | 0.81 | LMNA (0.70) | LMNAHPGDRAB9ANPC1MAPT | |
| SCHEMBL29475634 | 0.80 | LMNA (0.69) | CA12CA1CA2CA7CA9 | |
| SCHEMBL90412 | 0.80 | LMNA (0.69) | CA12CA1CA2CA7CA9 | |
| SCHEMBL18658361 | 0.80 | LMNA (0.39) | CA12CA1CA2CA7CA9 | |
| SCHEMBL1107602 | 0.79 | SMPD1 (0.56) | CA12CA1CA2CA7CA9 | |
| SCHEMBL20644671 | 0.79 | CA12 (0.41) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3604210 | 0.79 | MAOB (0.55) | CA12CA1CA2CA7CA9 | |
| SCHEMBL5177852 | 0.78 | MRGPRX4 (0.50) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150087601-A1 | POLYMER MICELLE COMPLEX INCLUDING NUCLEIC ACID | THE UNIVERSITY OF TOKYO (JP) | 2015-03-26 | — | — | US | disclosed |
| US-20150087601-A1 | POLYMER MICELLE COMPLEX INCLUDING NUCLEIC ACID | THE UNIVERSITY OF TOKYO (JP) | 2015-03-26 | — | — | US | disclosed |
| US-20090018216-A1 | POLYMER MICELLE COMPLEX INCLUDING NUCLEIC ACID | THE UNIVERSITY OF TOKYO (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20090018216-A1 | POLYMER MICELLE COMPLEX INCLUDING NUCLEIC ACID | THE UNIVERSITY OF TOKYO (JP) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150087601-A1 | POLYMER MICELLE COMPLEX INCLUDING NUCLEIC ACID | XRCC6, XRCC5, TLR9 | CA12 401/4885CA1 1026/4885CA2 1218/4885 |
| US-20090018216-A1 | POLYMER MICELLE COMPLEX INCLUDING NUCLEIC ACID | XRCC6, XRCC5, TLR9 | CA12 401/4885CA1 1026/4885CA2 1218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.